Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells. - Wikidata - awgldk - TriplyDB

Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells.

Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells.

http://www.wikidata.org/entity/Q45738814

about

EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR Hepatitis C virus proteins Host restriction factors for hepatitis C virus Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders.Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines.Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81 Recognition of native hepatitis C virus E1E2 heterodimers by a human monoclonal antibody.Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection A Conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr Motif in Hepatitis C Virus Glycoprotein E2 Is a Determinant of CD81 Binding and Viral Entry Virological analysis and phenotypic characterization of peripheral blood lymphocytes of hepatitis C virus-infected patients with and without mixed cryoglobulinaemia Altered expression of the tetraspanin CD81 on B and T lymphocytes during HIV-1 infection Expression and Characterization of a Minimal Hepatitis C Virus Glycoprotein E2 Core Domain That Retains CD81 Binding Interferon Alpha Treatment and Thyroid Dysfunction Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions CD81-Dependent Binding of Hepatitis C Virus E1E2 Heterodimers Hepatitis C Virus (HCV)-Induced Immunoglobulin Hypermutation Reduces the Affinity and Neutralizing Activities of Antibodies against HCV Envelope Protein Hepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis C CD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human Hepatocytes HCV E2 protein binds directly to thyroid cells and induces IL-8 production: A new mechanism for HCV induced thyroid autoimmunity Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2.Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults.Soluble serum CD81 is elevated in patients with chronic hepatitis C and correlates with alanine aminotransferase serum activity.Liver immunology.Complementary costimulation of human T-cell subpopulations by cluster of differentiation 28 (CD28) and CD81.Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis.Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies.Viral modulation of NK cell immunity.Viral modulation of T-cell receptor signaling Recent advances in our understanding of receptor binding, viral fusion and cell entry of hepatitis C virus: new targets for the design of antiviral agents.Interaction of interferon alpha therapy with thyroid function tests in the management of hepatitis C: a case report.Engagement of CD81 induces ezrin tyrosine phosphorylation and its cellular redistribution with filamentous actin.Hepatitis C virus (HCV): a review of immunological aspects.CD81 and hepatitis C virus (HCV) infection.A role for CD81 and hepatitis C virus in hepatoma mobility.Tetraspanins in cellular immunity.HCV proteins and immunoglobulin variable gene (IgV) subfamilies in HCV-induced type II mixed cryoglobulinemia: a concurrent pathogenetic role.Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis.

P2860

Q24530062-DA200F0D-639D-4594-A057-B091F05EAF11 Q24551041-8D3360BB-DCEF-4772-B7EF-DFDF7A6296B0 Q24563969-E9138D9C-DAB0-49E5-AD5D-8982E6885287 Q26773258-D138EE89-9AED-48DE-8FA6-F4BB1EFA24B4 Q27472760-B5E983C6-F3A8-4A43-87DE-149CC8B94E7D Q27472837-A096AB4F-2E59-453D-82BB-65CC224D4469 Q27472909-FB727343-E01B-4F39-815A-29061E0387BC Q27473084-F4C760AC-8C4D-4820-92B1-736CA9E82558 Q27473382-2A12EA31-43AE-4998-B3AB-94F2ED844801 Q27477463-721447E9-4414-4BA3-91D2-D009E5185ED0 Q27478129-B5E105B5-18D9-44EF-BE91-2FC76140D51B Q27478138-54502796-0E2C-496B-B7BA-E23384C0E664 Q27481026-ADDDA602-8E59-468C-80F4-A885123D04A3 Q27483686-F8A3DCAB-4143-4A19-B893-EE847100D5B1 Q27485143-0CF84212-7E40-4461-9730-8CDEC2721342 Q27485145-E5EE145F-F8F6-458D-B0CD-7F94D1AE4110 Q27485659-9D47F9D7-3806-43E3-9CEF-7201CBF093C5 Q27486411-90821A84-A597-4677-A5DF-982ADEA66920 Q27486537-B4BBA419-CEBA-415F-A46F-95AC9289F247 Q27486789-6DC7D366-419D-4115-8AC2-12B6A68F0822 Q27487927-23DFFA88-B02C-45EF-B35A-CE6FC3298191 Q29048140-AE6FD98E-C191-40FE-9A60-494B7C45FA5C Q33883727-00C5103F-7B94-4F07-8CB1-7E3A841AD700 Q34072573-F6DA0F29-0ECB-4281-B156-E6BA68754065 Q34166233-6C85A8E9-5BE3-4038-8405-9FC6EC69AE0B Q34359990-18DFC6AF-D9BE-4633-9E01-D1BBFFEC5779 Q35749676-A419F107-6D36-4C25-8FD8-5BE220529080 Q35817615-6BA913D7-6694-494C-A9BC-917A16F52CAC Q35911859-1CC72088-64D7-4D06-92DB-EF64C18085E0 Q35988761-B18E0C70-06F5-43A2-B888-D8EC2F57A047 Q36540182-9EE679F9-93D1-40A7-B141-BA4BF32D2F21 Q36956517-CA6C8E6D-2D3B-4C44-B3E0-C495F8D5D484 Q37260388-A7D11832-C900-4568-920E-3C09357054B7 Q37311443-10555013-9C95-4F3E-9CA0-65C65782BFC8 Q37344238-BB0E3B1A-F6CF-4E33-9063-99F66632E5D5 Q37611819-0C8E38B8-B6F8-4A59-A2DD-89EC667C0239 Q37673172-44FAAEF2-9E20-4D89-9274-52588AEFEB17 Q37856388-FD66638B-7961-49F3-A6DC-B6DC6F9A62AA Q38018062-A6F21C2A-88DF-4FFD-9360-1B4047660D7E Q38030534-E3DD05DF-E2D0-4FC6-8FEB-41987010927F

P2860

Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells.

http://www.wikidata.org/entity/Q45738814

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Binding of the hepatitis C vir ...... tory signal for human T cells.

@en

Binding of the hepatitis C vir ...... tory signal for human T cells.

@nl

type

label

Binding of the hepatitis C vir ...... tory signal for human T cells.

@en

Binding of the hepatitis C vir ...... tory signal for human T cells.

@nl

prefLabel

Binding of the hepatitis C vir ...... tory signal for human T cells.

@en

Binding of the hepatitis C vir ...... tory signal for human T cells.

@nl

P1433

Q45738814-03EB588C-09AC-4B0F-BB0C-5B70AF9F9311

P1476

Q45738814-5D9BE23B-41AE-40C6-90D0-41FE84A3B65D

P2093

Q45738814-0C68F42C-55E5-43AA-B0BC-EF66F62D13FF

Q45738814-26CFDA98-57E6-4F4F-83E1-6205229657A4

Q45738814-2D52667E-2874-4028-B78E-2A84E2739FE1

Q45738814-4E5561D9-185E-4166-A827-6F7198609AE9

Q45738814-B2F003A3-D67A-4610-A08A-E104610736D9

P2860

Q45738814-0CF74A01-421A-401A-9539-E968AD154CBE

Q45738814-0FAB15E3-23FC-42C3-8812-C792CB92305F

Q45738814-25176D36-070A-4765-A11A-C143AE72FDFD

Q45738814-39350167-C33E-4B35-8F96-865EB4ECB26E

Q45738814-3F656EF3-D26F-4A61-89CE-F2549587F82B

Q45738814-4B053307-83CC-4F04-A6BB-E7CD6366641C

Q45738814-5663129E-7BFB-40B1-AA9E-00DEDFD0699E

Q45738814-61EEAEB6-FBE3-47C8-A55C-E70423A78FD4

Q45738814-65ACC92F-9B33-4E02-AA6E-EF90D3E0428F

Q45738814-7128F0A5-1809-476E-8C8C-BDC4F32ADDEA

P304

Q45738814-BEF6D7CE-9D65-4AD2-A868-25B8F016428A

P31

Q45738814-CE66469E-D255-4117-A0B2-936D1DB5AB97

P356

Q45738814-86759539-8AD5-41AD-847A-5E9C623C3C37

P407

Q45738814-710775C5-F13E-4E4C-BDB1-B74E31F5876F

P433

Q45738814-BAEC5781-427A-4940-8E0C-0CD2BFF73DD2

P478

Q45738814-75997827-E50B-4CB6-A71B-077E4BC4E6DE

P50

Q45738814-2262C0F0-0FBA-4FEF-A61F-6969FAB5A6A4

P577

Q45738814-A66B55B5-BF60-4266-839C-DAD4CD1664AB

P698

Q45738814-79F32E57-4107-45F2-9A93-A5E3AC0F9F5C

P356

1521-4141(200101)31:1%3C166::AID-IMMU166%3E3.0.CO;2-L

P1433

European Journal of Immunology

P1476

Binding of the hepatitis C vir ...... tory signal for human T cells.

@en

P2093

Abrignani S

http://www.w3.org/2001/XMLSchema#string

Klimpel G

http://www.w3.org/2001/XMLSchema#string

Nuti S

http://www.w3.org/2001/XMLSchema#string

Soldaini E

http://www.w3.org/2001/XMLSchema#string

Tseng C

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of hepatitis C virus to CD81

TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins

Structure-function analysis of hepatitis C virus envelope-CD81 binding

Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates.

Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system

Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C.

T cell co-stimulatory molecules other than CD28.

Autoimmunity and extrahepatic manifestations in hepatitis C virus infection.

P304

166-175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1521-4141(200101)31:1<166::AID-IMMU166>3.0.CO;2-L

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

P577

2001-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11169450

http://www.w3.org/2001/XMLSchema#string